Stephan Weidinger is currently Professor and Chair for Dermatology at the Christian-Albrechts-University as well as Director of the Department of Dermatology and Allergy at the University Hospital Schleswig-Holstein, Campus Kiel, Germany. He qualified as a physician from the University of Regensburg, Germany, and following this he received his MD and PhD from the Technische Universität in Munich, Germany. Prior to his current position, Professor Weidinger held a senior physician position at the Department of Dermatology and Allergy, Technische Universität Munich, where he led the inflammatory skin disease unit.

In addition to his clinical and research roles, Professor Weidinger is an Associate Editor of the Journal of Allergy and Clinical Immunology and the British Journal of Dermatology, and Editorial Board member of the Journal of Investigative Dermatology and the Journal of the European Academy of Dermatology and Venereology.

Professor Weidinger’s main research interests lie in the molecular mechanisms and treatment of allergic and chronic inflammatory skin diseases, in particular atopic dermatitis, and he has published numerous peer-reviewed publications on this and other related topics.

He is coordinator of the international BIOMAP (Biomarkers in Atopic Dermatitis and Psoriasis) consortium funded by the European Union’s Horizon 2020 research and innovation programme and EFPIA, is involved in the EU/IMI ImmUniverse project, is principal investigator in the German Excellence Cluster “Precision Medicine in Inflammation” and of the German atopic dermatitis registry TREATGermany, and is involved in multiple clinical trials on atopic dermatitis, hand eczema and alopecia areata.

Professor Weidinger has also been presented with multiple awards including the Langerhans Award of the German Society for Dermatological Research (ADF), the PhARF (Phadia Allergy Research Forum) Award, the European Centre for Allergy Research Foundation (ECARF) Award, the Allergopharma Award, a Heisenberg fellowship of the German Research Council, and the Herxheimer Award of the German Society for Allergy and Clinical Immunology.